Department of Pediatric and Child Health, Kilimanjaro Christian Medical Center, Moshi, Tanzania.
Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Sci Rep. 2021 Nov 23;11(1):22759. doi: 10.1038/s41598-021-02186-2.
Extended-Spectrum Beta-Lactamase (ESBL) producing Enterobacteriaceae (EPE) is increasing worldwide, though less documented in low-income settings. Here we determined the prevalence of EPE infection and carriage, and patient factors associated with EPE-carriage among pediatric patients in three health care levels in Tanzania. Between January and April 2016, 350 febrile children (median age 21 months) seeking care at a university or a regional referral hospital, or a health centre in Moshi municipality, Tanzania, were included. Socio-demographic characteristics were collected using a questionnaire. Rectal swabs and blood cultures were collected from all children (n = 350) and urinary samples from 259 children at admission. ESBL-phenotype and antimicrobial susceptibility were determined for Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) isolates. Only one EPE case (E. coli) in blood and four in urine (one E. coli and three K. pneumoniae) were found, whereas (n = 90, 26%) of the children were colonized in feces (ESBL-E. coli; n = 76, ESBL-K. pneumoniae, n = 14). High resistance rates were seen in fecal ESBL-E. coli (n = 76) against trimethoprim-sulfamethoxazole (n = 69, 91%), gentamicin (n = 51, 67%), ciprofloxacin (n = 39, 51%) and chloramphenicol (n = 27, 35%) whereas most isolates were sensitive to amikacin (n = 71, 93%). Similar rates were seen for fecal ESBL-K. pneumoniae. Resistance to first line antibiotics were also very high in fecal E. coli not producing ESBL. No sociodemographic factor was associated with EPE-carriage. Children colonized with EPE were younger than 12 months (n = 43, 48%) and often treated with antibiotics (n = 40, 44%) in the previous two months. After adjustment for age children admitted to the intensive care unit had higher odds of EPE fecal carriage compared with those in the general wards (OR = 3.9, 95%CI = 1.4-10.4). Despite comparatively high rates of fecal EPE-carriage and previous antibiotic treatment, clinical EPE cases were rare in the febrile children. The very high resistant rates for the EPE and the non-ESBL producing E. coli to commonly used antibiotics are worrying and demand implementation of antibiotic stewardship programs in all levels of health care in Tanzania.
产超广谱β-内酰胺酶(ESBL)肠杆菌科(EPE)在全球范围内不断增加,尽管在低收入环境中的记录较少。在这里,我们确定了坦桑尼亚三个医疗保健水平的儿科患者中 EPE 感染和携带情况以及与 EPE 携带相关的患者因素。2016 年 1 月至 4 月期间,共纳入 350 名在坦桑尼亚大学或地区转诊医院或莫希市医疗中心寻求医疗服务的发热儿童(中位年龄 21 个月)。使用问卷收集社会人口统计学特征。对所有儿童(n=350)和 259 名入院儿童的直肠拭子和血培养进行了收集。对肺炎克雷伯菌(K. pneumoniae)和大肠埃希菌(E. coli)分离株进行了 ESBL 表型和抗菌药物敏感性检测。仅在血液中发现了 1 例 EPE 病例(E. coli)和 4 例尿液(1 例 E. coli 和 3 例 K. pneumoniae),而 90 例(26%)儿童粪便中存在定植(ESBL-E. coli,n=76;ESBL-K. pneumoniae,n=14)。粪便 ESBL-E. coli(n=76)对复方磺胺甲噁唑(n=69,91%)、庆大霉素(n=51,67%)、环丙沙星(n=39,51%)和氯霉素(n=27,35%)的耐药率很高,而大多数分离株对阿米卡星(n=71,93%)敏感。粪便 ESBL-K. pneumoniae 也存在类似的耐药率。未产生 ESBL 的粪便 E. coli 对一线抗生素的耐药率也很高。EPE 定植与社会人口统计学因素无关。携带 EPE 的儿童年龄小于 12 个月(n=43,48%),且经常在过去两个月内接受抗生素治疗(n=40,44%)。在调整年龄后,与普通病房的儿童相比,入住重症监护病房的儿童粪便携带 EPE 的可能性更高(OR=3.9,95%CI=1.4-10.4)。尽管粪便 EPE 携带率和之前的抗生素治疗率较高,但发热儿童中临床 EPE 病例很少见。EPE 和非产 ESBL 的大肠埃希菌对常用抗生素的高度耐药率令人担忧,需要在坦桑尼亚各级医疗保健中实施抗生素管理计划。